8-K - Theravance Biopharma, Inc. | StockGist

Current Report Details

Event Type

Financial Results

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

2.02

and in Item 9.01 of this Current Report on Form 8-K, including Exhibits 99.1 and 99.2, is being furnished and shall not be deemed “filed” for the purposes of Se

Financial Results

9.01

. Financial Statements and Exhibits. (d) Exhibits. 99.1 Press Release dated May 8 2025 99.2 Slide deck entitled First Quarter 2025 Financial Results and Busines

Exhibits Only

Source Document

Exhibits (3)

8-K

FORM 8-K

99.1

EXHIBIT 99.1

99.2

EXHIBIT 99.2